Aduro Clean Technologies Appoints VP of Engineering and Initiates New Marketing Efforts
Aduro Clean Technologies (Nasdaq: ADUR) has announced two significant developments in its commercialization journey. The company has appointed Dr. Arturo Gomez as Vice President of Engineering, bringing over 20 years of expertise in process engineering and chemical process design. Dr. Gomez will play a important role in completing the company's Hydrochemolytic™ Technology (HCT) pilot plant, scheduled for commissioning in Q3 2025.
Additionally, Aduro has entered into a marketing agreement with Outside The Box Capital (OTBC) for a 12-month term starting January 15th, 2025. The agreement includes C$360,000 in cash compensation and 40,000 stock options. OTBC will provide marketing and investor relations services through various social media platforms. The company has also granted 270,000 stock options to certain employees, exercisable at C$9.00 per share over two years.
Aduro Clean Technologies (Nasdaq: ADUR) ha annunciato due sviluppi significativi nel suo percorso di commercializzazione. L'azienda ha nominato Dr. Arturo Gomez come Vice Presidente dell'Ingegneria, portando con sé oltre 20 anni di esperienza nell'ingegneria dei processi e nella progettazione dei processi chimici. Il Dr. Gomez avrà un ruolo importante nel completamento dell'impianto pilota della tecnologia Hydrochemolytic™ (HCT), previsto per il commissioning nel terzo trimestre del 2025.
Inoltre, Aduro ha stipulato un accordo di marketing con Outside The Box Capital (OTBC) per un periodo di 12 mesi a partire dal 15 gennaio 2025. L'accordo include un compenso in contante di C$360.000 e 40.000 opzioni su azioni. OTBC fornirà servizi di marketing e relazioni con gli investitori attraverso varie piattaforme di social media. L'azienda ha anche concesso 270.000 opzioni su azioni a determinati dipendenti, esercitabili a C$9,00 per azione nel corso di due anni.
Aduro Clean Technologies (Nasdaq: ADUR) ha anunciado dos desarrollos significativos en su camino hacia la comercialización. La empresa ha nombrado al Dr. Arturo Gomez como Vicepresidente de Ingeniería, aportando más de 20 años de experiencia en ingeniería de procesos y diseño de procesos químicos. El Dr. Gomez desempeñará un papel importante en la finalización de la planta piloto de la tecnología Hydrochemolytic™ (HCT), programada para su puesta en marcha en el tercer trimestre de 2025.
Además, Aduro ha firmado un acuerdo de marketing con Outside The Box Capital (OTBC) por un período de 12 meses que comienza el 15 de enero de 2025. El acuerdo incluye C$360,000 en compensación en efectivo y 40,000 opciones sobre acciones. OTBC brindará servicios de marketing y relaciones con inversionistas a través de varias plataformas de redes sociales. La empresa también ha otorgado 270,000 opciones sobre acciones a ciertos empleados, que se pueden ejercer a C$9.00 por acción durante dos años.
Aduro Clean Technologies (Nasdaq: ADUR)은 상업화 여정에서 두 가지 중요한 발전을 발표했습니다. 회사는 Dr. Arturo Gomez를 엔지니어링 부사장으로 임명했으며, 20년 이상의 공정 엔지니어링 및 화학 공정 설계 경험을 제공합니다. Dr. Gomez는 2025년 3분기 제품 가동 예정인 회사의 Hydrochemolytic™ Technology (HCT) 파일럿 플랜트 완공에 중요한 역할을 할 것입니다.
또한, Aduro는 2025년 1월 15일부터 시작되는 12개월 기간의 Outside The Box Capital (OTBC)와 마케팅 계약을 체결했습니다. 계약에는 C$360,000의 현금 보상과 40,000개의 주식 옵션이 포함되어 있습니다. OTBC는 다양한 소셜 미디어 플랫폼을 통해 마케팅 및 투자자 관계 서비스를 제공할 것입니다. 회사는 또한 특정 직원에게 총 270,000개의 주식 옵션을 부여했으며, 이 옵션은 2년 동안 C$9.00의 가격으로 행사할 수 있습니다.
Aduro Clean Technologies (Nasdaq: ADUR) a annoncé deux développements significatifs dans son parcours de commercialisation. L'entreprise a nommé Dr. Arturo Gomez au poste de Vice-Président de l'Ingénierie, apportant plus de 20 ans d'expertise en ingénierie des procédés et en conception de processus chimiques. Le Dr. Gomez jouera un rôle important dans l'achèvement de l'usine pilote de la technologie Hydrochemolytic™ (HCT), prévue pour mise en service au troisième trimestre 2025.
De plus, Aduro a conclu un accord de marketing avec Outside The Box Capital (OTBC) pour une durée de 12 mois à partir du 15 janvier 2025. L'accord comprend une compensation en espèces de 360 000 C$ et 40 000 options d'actions. OTBC fournira des services de marketing et de relations investisseurs via diverses plateformes de médias sociaux. L'entreprise a également accordé 270 000 options d'actions à certains employés, exerçables à 9,00 C$ par action pendant deux ans.
Aduro Clean Technologies (Nasdaq: ADUR) hat zwei bedeutende Entwicklungen in seiner Kommerzialisierungsreise bekannt gegeben. Das Unternehmen hat Dr. Arturo Gomez zum Vice President Engineering ernannt und bringt über 20 Jahre Erfahrung in der Verfahrenstechnik und chemischen Prozessgestaltung mit. Dr. Gomez wird eine wichtige Rolle beim Abschluss der Pilotanlage zur Hydrochemolytic™ Technology (HCT) spielen, die für das dritte Quartal 2025 in Betrieb genommen werden soll.
Darüber hinaus hat Aduro einen Marketingvertrag mit Outside The Box Capital (OTBC) für eine Laufzeit von 12 Monaten ab dem 15. Januar 2025 abgeschlossen. Der Vertrag umfasst eine Barvergütung von 360.000 C$ und 40.000 Aktienoptionen. OTBC wird Marketing- und Investor Relations-Dienstleistungen über verschiedene soziale Medienplattformen bereitstellen. Das Unternehmen hat auch 270.000 Aktienoptionen bestimmten Mitarbeitern gewährt, die innerhalb von zwei Jahren zu einem Preis von 9,00 C$ pro Aktie ausgeübt werden können.
- Strategic appointment of experienced VP of Engineering strengthens technical leadership
- HCT pilot plant commissioning on track for Q3 2025
- Enhanced marketing initiatives through comprehensive social media coverage
- Significant marketing expenses with C$360,000 cash compensation to OTBC
- Potential dilution from 310,000 total new stock options granted
Dr. Arturo Gomez Appointed as Vice President of Engineering Aduro Expands Marketing Initiatives with Outside The Box Capital
LONDON, Ontario, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announces key developments in its commercialization journey. As the Company prepares to commission its Hydrochemolytic™ Technology (HCT) pilot plant in Q3 2025, Aduro has appointed Dr. Arturo Gomez as Vice President of Engineering and entered into a new marketing agreement with Outside The Box Capital (“OTBC”).
Dr. Arturo Gomez as Vice President of Engineering:
Arturo’s career includes senior engineering roles at leading organizations such as MilliporeSigma (a Merck KGaA), Lanxess and Bartek Ingredients. He has successfully led initiatives involving automation, process design, and the development of innovative chemical solutions, delivering improved efficiency and cost-effectiveness. Gomez holds a Ph.D. in Chemical and Petroleum Engineering from the University of Calgary and is a licensed Professional Engineer (P.Eng.).
Aduro continues to enhance its strong engineering team alongside the Company’s R&D and Operations teams. Hiring Dr. Gomez underscores Aduro’s commitment to support the process scale-up of its HCT. As Aduro works toward commissioning its HCT Pilot Plant in the third quarter of this year, Dr. Gomez’s expertise in process scale-up will prove invaluable in completing the pilot plant and advancing the future HCT commercial demonstration plant, further driving Aduro’s progress on the path towards commercialization.
Onboarding Dr. Gomez strengthens the Company’s engineering capabilities. He brings over 20 years of expertise in process engineering and chemical process design, including leading teams through the successful transition of technologies from laboratory and pilot phases to commercial-scale operations. Dr. Gomez has a history of managing complex projects in reactor design, advanced materials manufacturing, and chemical process optimization, positioning Aduro for a stronger path towards commercialization.
“We are excited to welcome Arturo to the Aduro team. His depth of experience in chemical process development and process scale-up will strengthen our engineering capabilities and will help drive the commercialization of our Hydrochemolytic™ platform,” said Ofer Vicus, CEO of Aduro. “In recent months, our focus has shifted to strengthening our engineering capabilities, and we’re all excited to welcome him to Team Aduro as we continue progressing toward our key milestones.”
“Joining Aduro is a unique opportunity to contribute to the development of this very special chemical technology platform,” said Dr. Gomez. “I look forward joining the team and collaborating to advance our efforts to scale-up our technology.”
Marketing and Investor Relations Agreement with Outside the Box Capital
The Company also announces that it has entered into a marketing and consulting agreement with the arm’s length marketing firm OTBC, of Oakville, Ontario, to build awareness as the Company continues to work on delivering key milestones and to provide marketing consulting and investor relations services, including marketing through OTBC’s social media channels and online media distribution. Specifically, OTBC will employ various social media platforms, including Reddit, Discord, Telegram, X, StockTwits, YouTube, and Facebook to bring investor awareness to the Company.
Under the OTBC Agreement, for an initial term of twelve months starting on January 15th, 2025 (the “Effective Date”), Aduro will pay OTBC an aggregate cash compensation of C
This continued engagement with OTBC builds on prior successes in creating awareness and communication with the investor community, further expanding the Company's visibility. OTBC’s expertise in leveraging social media platforms has effectively facilitated broader awareness and widespread dissemination of the Company status reports and updates.
Grant of Options
The Company also announces that certain employees will be granted an aggregate of 270,000 stock options (each, an “Incentive Option”) to purchase up to 270,000 common shares of the Company. The Incentive Options are exercisable for two years from the date of grant at a price of C
All 270,000 of the Incentive Options and the common shares underlying the Incentive Options are subject to a hold period of four months and one day from the date of grant.
None of the securities acquired upon exercise of the stock options issued by the Company will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act.
This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.
About Aduro Clean Technologies
Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.
For further information, please contact:
Abe Dyck, Head of Business Development and Investor Relations
ir@adurocleantech.com
+1 226 784 8889
KCSA Strategic Communications
Jack Perkins, Vice President
aduro@kcsa.com
Forward-Looking Statements
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future, are forward-looking statements. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. In this news release, the forward-looking statements include, but are not limited to, the Company’s plans to commission its HCT pilot plant in Q3 2025; the Company enhancing its engineering team to support the HCT pilot plant commissioning; that Dr. Arturo Gomez will help complete the pilot plant and advance the future HCT commercial demonstration plant; that Aduro is progressing towards commercializing its Hydrochemolytic™ technology; that OTBC’s social media expertise will continue to increase awareness of the Company; that Aduro’s continued engagement with OTBC aims to expand its market visibility. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Important factors that could cause actual results to differ materially from the Company’s expectations include, but are not limited to, adverse market conditions could impact the Company's ability to achieve its goals, including the commissioning of the HCT pilot plant and the commercialization of its technology; the success of the HCT pilot plant and future commercial demonstration plant depend on overcoming engineering and technical challenges, and any delays or failures in these areas could hinder progress; the Company’s operations and commercialization efforts are subject to various regulatory approvals, and any delays or failures in obtaining these approvals could impact the Company's timelines and objectives; the Company’s ability to execute its plans depends on having sufficient financial resources and any limitations in funding could affect the Company's ability to achieve its milestones; the success of the Company's marketing and commercialization efforts relies on effective partnerships and collaborations, such as the agreement with OTBC, and any issues in these relationships could impact the Company's visibility and progress; the commercial success of the Company's technology depends on market acceptance, and any resistance or slow adoption by the market could affect the Company's growth and business prospects; broader economic and political factors, including changes in government policies, economic downturns, or geopolitical tensions, could impact the Company's operations and market opportunities; the Company operates in a competitive industry and any advancements by competitors or changes in the competitive landscape could affect the Company's market position and growth prospects; and other factors beyond the control of the parties. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events, or otherwise, except as required by applicable law.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a38439fc-4e84-405a-b6ac-617104c3a630
FAQ
When will Aduro Clean Technologies (ACTHF) commission its HCT pilot plant?
What is the value of Aduro's marketing agreement with Outside The Box Capital?
How many stock options did Aduro grant to employees in January 2025?